ScholarIQanswers from OpenAlex & ORCID
Andreas Jeromin
ResearcherPublications, citations & collaboration network
Andreas Jeromin is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Andreas Jeromin have?
ScholarIQindexed works
Andreas Jeromin has 299 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Andreas Jeromin have?
ScholarIQcitation count
Andreas Jeromin has 18,736 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Andreas Jeromin?
ScholarIQh-index
Andreas Jeromin has an h-index of 67 in OpenAlex.
What is the i10-index of Andreas Jeromin?
ScholarIQi10-index
Andreas Jeromin has an i10-index of 173 in OpenAlex.
What is the OpenAlex record for Andreas Jeromin?
ScholarIQopenalex
The OpenAlex for Andreas Jeromin is on the source record.
What are the most-cited papers on Andreas Jeromin?
ScholarIQmost cited works
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study
Elisabeth H. Thijssen, Renaud La Joie, Amelia Strom, Corrina Fonseca, Leonardo Iaccarino, Amy Wolf, Salvatore Spina, Isabel Elaine Allen, Yann Cobigo, Hilary W. Heuer, Lawren VandeVrede, Nicholas K. Proctor, Argentina Lario Lago, Suzanne L. Baker, Rajeev Sivasankaran, Agnieszka Kieloch, Arvind G. Kinhikar, Lili Yu, Marie‐Anne Valentin, Andreas Jeromin, Henrik Zetterberg, Oskar Hansson, Niklas Mattsson, Danielle Graham, Kaj Blennow, Joel H. Kramer, Lea T. Grinberg, William W. Seeley, Howard J. Rosen, Bradley F. Boeve, Bruce L. Miller, Charlotte E. Teunissen, Gil D. Rabinovici, Julio C. Rojas, Jeffrey L. Dage, Adam L. Boxer
The future of blood‐based biomarkers for Alzheimer's disease
Kim Henriksen, Sid E. O’Bryant, Harald Hampel, John Q. Trojanowski, Thomas J. Montine, Andreas Jeromin, Kaj Blennow, Anders Lönneborg, Tony Wyss‐Coray, Holly Soares, Chantal Bazenet, Magnus Sjögren, William T. Hu, Simon Lovestone, M.A. Karsdal, Michael W. Weiner, Blood‐Based Biomarker Interest Group
Blood‐based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic
Sid E. O’Bryant, Michelle M. Mielke, Robert A. Rissman, Simone Lista, Hugo Vanderstichele, Henrik Zetterberg, Piotr Lewczuk, Holly Posner, James Hall, Leigh Johnson, Y L Fong, Johan Luthman, Andreas Jeromin, Richard Batrla‐Utermann, Alcibiades E. Villarreal, Gabrielle B. Britton, Peter J. Snyder, Kim Henriksen, Paula Grammas, Veer Bala Gupta, Ralph N. Martins, Harald Hampel, Biofluid Based Biomarker Professional Interest Area
Guidelines for the standardization of preanalytic variables for blood‐based biomarker studies in Alzheimer's disease research
Sid E. O’Bryant, Veer Bala Gupta, Kim Henriksen, Melissa Edwards, Andreas Jeromin, Simone Lista, Chantal Bazenet, Holly Soares, Simon Lovestone, Harald Hampel, Thomas J. Montine, Kaj Blennow, Tatiana Foroud, María C. Carrillo, Neill R. Graff‐Radford, Christoph Laske, Monique M.B. Breteler, Leslie M. Shaw, John Q. Trojanowski, Nicole Schupf, Robert A. Rissman, Anne M. Fagan, Pankaj Oberoi, Robert M. Umek, Michael W. Weiner, Paula Grammas, Holly Posner, Ralph N. Martins, STAR-B and BBBIG working groups
Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases
Alberto Lleó, Enrica Cavedo, Lucilla Parnetti, Hugo Vanderstichele, Sanna Kaisa Herukka, Niels Andreasen, Roberta Ghidoni, Piotr Lewczuk, Andreas Jeromin, Bengt Winblad, Magda Tsolaki, Barbara Mroczko, Pieter Jelle Visser, Isabel Santana, Per Svenningsson, Kaj Blennow, Dag Aarsland, José Luís Molinuevo, Henrik Zetterberg, Brit Mollenhauer